Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 04/21/2020

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Michael Berry MD, FACS None None None None NA
Marian Birkeland PhD None None None None NA -
Saundra Buys MD None None None None NA
Mary Daly MD, PhD, FACP None None None None NA
Susan Darlow PhD None None None None NA
Patricia Dickson MD None None None None NA
Susan Domchek MD None None None None NA
Mary Dwyer MS None None None None NA
Ahmed Elkhanany MD None Biotheranostics
Pfizer Inc.
None None NA
Susan Friedman DVM None None None None NA
Judy Garber MD, MPH Ambry Genetics
AstraZeneca Pharmaceuticals LP
Invitae Genetics
Myriad Genetic Laboratories, Inc.
Adrienne Helis Melvin Research Foundation
Aleta Bio-Therapeutics
American Association for Cancer Research
American Society of Clinical Oncology
Diane Helis Henry Medical Research Foudation
GTx, Inc.
GV20 Therapeutics
H3 Biomedicine, Inc.
Helix Genetics
James P. Wilmot Foundation Inc.
Konica Minolta
Kronos Bio
Novartis Pharmaceuticals Corporation
Susan G. Komen for the Cure
None Breast Cancer Research Foundation NA -
Michael Goggins MD None None None None NA
Kristina Gregory MSN, RN, OCN None None None None NA
Laura Hanisch PsyD None None None None NA -
Mollie Hutton MS, CGC None None None None NA
Seema Khan MD None None None None NA
Catherine Klein MD None None None None NA
Wendy Kohlmann MS, CGC None None None None NA
Allison Kurian MD, MSc None None None None NA
Christine Laronga MD, FACS None None None None NA -
Jennifer Litton MD AstraZeneca Pharmaceuticals LP
EMD Serono
Genentech, Inc.
paxman scalp cooler
Pfizer Inc.
zenith
None clinical care options
Medlearning
Medscape
Physicians Education Resource
Prime Oncology
uptodate
Up To Date NA
Julie Mak MS, MSc None None None None NA
Carolyn Menendez MD None None None None NA
Sofia Merajver MD, PhD None None None Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. NA
Barbara Norquist MD None None None None NA
Kenneth Offit MD None None None None NA
Tuya Pal MD None None None None NA
Holly Pederson MD None Myriad Genetic Laboratories, Inc. None None NA -
Robert Pilarski MS, MSW, LGC None None None None NA
Gwen Reiser MS, CGC None None None None NA
Kristen Shannon MS, CGC None Expert Witness None None NA
Rebecca Shatsky MD Biocept
Genentech, Inc.
Oncternal Inc.
Phoenix Molecular Designs
None None None NA
Kala Visvanathan MD, MHS Cepheid
Optra Health
None None None NA -
Jeffrey Weitzel MD None None AstraZeneca Pharmaceuticals LP None NA
Myra Wick MD, PhD None None None None NA
Kari Wisinski MD AstraZeneca Pharmaceuticals LP
Context Therapeutics
Eli Lilly and Company
Genentech, Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
sanofi-aventis U.S.
AstraZeneca Pharmaceuticals LP
Eisai Inc.
Pfizer Inc.
None None NA
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP UpToDate None None NA